作者
Guillaume Fond, Laurent Boyer, Mohamed Boucekine, Latif A Aden, Franck Schürhoff, Arnaud Tessier, Meja Andrianarisoa, Fabrice Berna, Lore Brunel, Delphine Capdevielle, Isabelle Chereau, Jasmina Mallet, Hélène Denizot, Jean Michel Dorey, Caroline Dubertret, Julien Dubreucq, Catherine Faget, Franck Gabayet, Romain Rey, Raphaelle Richieri, Christine Passerieux, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre Michel Llorca, David Misdrahi
发表日期
2017/4/1
期刊
Schizophrenia research
卷号
182
页码范围
84-89
出版商
Elsevier
简介
Objective
The Medication Adherence Rating Scale (MARS) is one of the most widely used measurements of adherence in schizophrenia (SZ). However, the data available regarding its psychometric properties are scarce. The aim of this study was to provide new data regarding the psychometric properties of the MARS in a multicenter community-dwelling sample of SZ patients.
Methods
This study was conducted in the French National network of the 10 FondaMental Expert Centers for SZ. The MARS was tested for construct validity, reliability, external validity and acceptability. In addition, data pertaining to sociodemographic information, clinical characteristics using the Positive and Negative Syndrome Scale (PANSS), the Scale to Assess Unawareness in Mental Disorder (SUMD), the Calgary Depression Scale for Schizophrenia (CDRS) and therapeutic adherence using the Brief Adherence Rating Scale (BARS …
学术搜索中的文章
Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset
G Fond, L Boyer, M Boucekine, LA Aden, F Schürhoff… - Schizophrenia research, 2017
